Mark Munson
Co-founderDr. Mark Munson, Ph.D., is serves as Co-Founder and served as Co-founder and Senior Vice President of Medicinal Chemistry at Sionna Therapeutics, Inc until September 2026. and served as its Vice President of Medicinal Chemistry. Formerly, he was the U.S. head of medicinal chemistry at Sanofi where he oversaw a diverse group of scientists that advanced forward multiple development candidates in oncology and rare disease. He also contributed to several external partnerships including Principia, MyoKardia, Lead Pharma and DiCE. He was a founding member of Array Biopharma (acquired by Pfizer) where he led several programs into clinical development (ARRY-797, ARRY-382 and pexmetinib). He began his career at Amgen where he created and led the highspeed synthesis group. He received his Ph.D. in chemistry from the University of Minnesota and his B.S. from Macalester College.
Positions
- Company NameSionna Therapeutics, Inc.Stock CodeSIONPositionCo-founderColleagues
- MCMichael CloonanPresident, CEO & Director
- PJPaul J. ClancyIndependent Chairman
- EHElena H. RidloffCFO & Chief Business Officer
- GHGreg HurlbutCo-Founder & Senior VP of Discovery Research
- ACAndy ChuVice President of Information & Technology
- LDLaurie D. StelzerIndependent Director
- JLJoanne Louise VineyIndependent Director
- JRJoshua ResnickIndependent Director
